JP6262562B2

JP6262562B2 - 携帯電話およびイヤホン

携帯電話およびイヤホン Download PDF

Info

Publication number: JP6262562B2
Authority: JP; Japan
Prior art keywords: mobile phone; cartilage conduction; ear; unit; vibration
Prior art date: 2014-02-20
Legal status : Active

Application number

JP2014030835A

Other languages

English (en)

Japanese (ja)

Other versions

JP2015156574A5 (enrdf_load_stackoverflow

JP2015156574A (ja

Inventor

裕司細井

田中　雅英

雅英田中

Current Assignee

Rohm Co Ltd

Finewell Co Ltd

Original Assignee

Rohm Co Ltd

Finewell Co Ltd

Priority date

2014-02-20

Filing date

2014-02-20

Publication date

2018-01-17

2014-02-20 Priority to JP2014030835A priority Critical patent/JP6262562B2/ja

2014-02-20 Application filed by Rohm Co Ltd, Finewell Co Ltd filed Critical Rohm Co Ltd

2014-08-19 Priority to CN201480046533.1A priority patent/CN105493478B/zh

2014-08-19 Priority to PCT/JP2014/071607 priority patent/WO2015025829A1/ja

2014-08-19 Priority to EP20166767.2A priority patent/EP3694191A1/en

2014-08-19 Priority to EP14837349.1A priority patent/EP3038330B1/en

2014-08-19 Priority to HK16105922.4A priority patent/HK1218030B/zh

2014-08-19 Priority to KR1020187019084A priority patent/KR101972290B1/ko

2014-08-19 Priority to KR1020167004740A priority patent/KR101877652B1/ko

2014-08-19 Priority to CN201810260704.0A priority patent/CN108551507A/zh

2014-08-22 Priority to TW103129060A priority patent/TWI604714B/zh

2014-08-22 Priority to TW106130063A priority patent/TWI728180B/zh

2014-08-22 Priority to TW109104876A priority patent/TWI754896B/zh

2015-08-27 Publication of JP2015156574A publication Critical patent/JP2015156574A/ja

2016-02-22 Priority to US15/049,403 priority patent/US9742887B2/en

2016-05-24 Priority to HK18115547.6A priority patent/HK1256415A1/zh

2017-02-09 Publication of JP2015156574A5 publication Critical patent/JP2015156574A5/ja

2017-06-07 Priority to US15/616,144 priority patent/US10075574B2/en

2018-01-17 Application granted granted Critical

2018-01-17 Publication of JP6262562B2 publication Critical patent/JP6262562B2/ja

2018-07-26 Priority to US16/045,906 priority patent/US10237382B2/en

Status Active legal-status Critical Current

2034-02-20 Anticipated expiration legal-status Critical

Links

210000000845 cartilage Anatomy 0.000 claims description 1651
210000004728 ear cartilage Anatomy 0.000 claims description 581
230000005540 biological transmission Effects 0.000 claims description 195
239000004020 conductor Substances 0.000 claims description 154
230000001413 cellular effect Effects 0.000 claims description 133
210000000988 bone and bone Anatomy 0.000 claims description 124
239000000463 material Substances 0.000 claims description 101
238000000034 method Methods 0.000 description 533
230000008569 process Effects 0.000 description 518
230000006870 function Effects 0.000 description 388
210000000613 ear canal Anatomy 0.000 description 382
238000010586 diagram Methods 0.000 description 233
238000012986 modification Methods 0.000 description 207
230000004048 modification Effects 0.000 description 207
238000004891 communication Methods 0.000 description 179
241000746998 Tragus Species 0.000 description 147
238000012545 processing Methods 0.000 description 140
230000005236 sound signal Effects 0.000 description 135
230000007613 environmental effect Effects 0.000 description 121
230000000694 effects Effects 0.000 description 116
230000001133 acceleration Effects 0.000 description 89
238000001514 detection method Methods 0.000 description 74
230000008859 change Effects 0.000 description 69
230000004044 response Effects 0.000 description 66
230000008901 benefit Effects 0.000 description 64
239000011521 glass Substances 0.000 description 58
238000006243 chemical reaction Methods 0.000 description 52
210000003454 tympanic membrane Anatomy 0.000 description 45
238000003825 pressing Methods 0.000 description 43
239000002184 metal Substances 0.000 description 38
210000003811 finger Anatomy 0.000 description 37
239000000853 adhesive Substances 0.000 description 35
230000001070 adhesive effect Effects 0.000 description 35
238000005452 bending Methods 0.000 description 34
230000033001 locomotion Effects 0.000 description 31
238000005259 measurement Methods 0.000 description 28
210000005069 ears Anatomy 0.000 description 24
229920002379 silicone rubber Polymers 0.000 description 22
239000004945 silicone rubber Substances 0.000 description 22
MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 21
230000002829 reductive effect Effects 0.000 description 21
230000007423 decrease Effects 0.000 description 20
230000000903 blocking effect Effects 0.000 description 18
239000000203 mixture Substances 0.000 description 18
230000001012 protector Effects 0.000 description 18
210000003027 ear inner Anatomy 0.000 description 17
210000003128 head Anatomy 0.000 description 17
210000001595 mastoid Anatomy 0.000 description 17
229920005989 resin Polymers 0.000 description 17
239000011347 resin Substances 0.000 description 17
239000013013 elastic material Substances 0.000 description 15
244000043261 Hevea brasiliensis Species 0.000 description 14
210000000624 ear auricle Anatomy 0.000 description 14
229920003052 natural elastomer Polymers 0.000 description 14
229920001194 natural rubber Polymers 0.000 description 14
230000035945 sensitivity Effects 0.000 description 14
238000003860 storage Methods 0.000 description 14
210000001508 eye Anatomy 0.000 description 13
239000005062 Polybutadiene Substances 0.000 description 12
229920002857 polybutadiene Polymers 0.000 description 12
230000007704 transition Effects 0.000 description 12
238000005520 cutting process Methods 0.000 description 11
238000002156 mixing Methods 0.000 description 11
238000005070 sampling Methods 0.000 description 11
239000010410 layer Substances 0.000 description 10
238000013461 design Methods 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 9
230000001629 suppression Effects 0.000 description 9
WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 8
239000000919 ceramic Substances 0.000 description 8
238000003780 insertion Methods 0.000 description 8
230000037431 insertion Effects 0.000 description 8
230000007257 malfunction Effects 0.000 description 8
230000001681 protective effect Effects 0.000 description 8
230000035939 shock Effects 0.000 description 8
210000001260 vocal cord Anatomy 0.000 description 8
210000000707 wrist Anatomy 0.000 description 8
VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 7
CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 7
125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 7
238000012937 correction Methods 0.000 description 7
238000002955 isolation Methods 0.000 description 7
210000004373 mandible Anatomy 0.000 description 7
238000012360 testing method Methods 0.000 description 7
210000000216 zygoma Anatomy 0.000 description 7
BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 6
KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 6
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 6
210000000883 ear external Anatomy 0.000 description 6
230000003601 intercostal effect Effects 0.000 description 6
239000004973 liquid crystal related substance Substances 0.000 description 6
210000003205 muscle Anatomy 0.000 description 6
230000036961 partial effect Effects 0.000 description 6
239000000047 product Substances 0.000 description 6
230000009467 reduction Effects 0.000 description 6
XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 6
230000008034 disappearance Effects 0.000 description 5
238000009826 distribution Methods 0.000 description 5
238000000465 moulding Methods 0.000 description 5
238000012856 packing Methods 0.000 description 5
230000002093 peripheral effect Effects 0.000 description 5
210000002374 sebum Anatomy 0.000 description 5
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
229920002554 vinyl polymer Polymers 0.000 description 5
HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 4
208000032041 Hearing impaired Diseases 0.000 description 4
230000009471 action Effects 0.000 description 4
230000003321 amplification Effects 0.000 description 4
238000013459 approach Methods 0.000 description 4
210000003477 cochlea Anatomy 0.000 description 4
230000008878 coupling Effects 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
210000001162 elastic cartilage Anatomy 0.000 description 4
238000011049 filling Methods 0.000 description 4
238000007667 floating Methods 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
230000002265 prevention Effects 0.000 description 4
ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 3
KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 3
AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 3
239000004820 Pressure-sensitive adhesive Substances 0.000 description 3
LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 3
230000006399 behavior Effects 0.000 description 3
239000003990 capacitor Substances 0.000 description 3
239000002131 composite material Substances 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
239000000470 constituent Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
230000005674 electromagnetic induction Effects 0.000 description 3
230000008030 elimination Effects 0.000 description 3
238000003379 elimination reaction Methods 0.000 description 3
210000000887 face Anatomy 0.000 description 3
239000000945 filler Substances 0.000 description 3
238000003384 imaging method Methods 0.000 description 3
230000001771 impaired effect Effects 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
238000001228 spectrum Methods 0.000 description 3
239000013589 supplement Substances 0.000 description 3
229920003002 synthetic resin Polymers 0.000 description 3
239000000057 synthetic resin Substances 0.000 description 3
239000010409 thin film Substances 0.000 description 3
206010011878 Deafness Diseases 0.000 description 2
230000003139 buffering effect Effects 0.000 description 2
210000000038 chest Anatomy 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
238000011109 contamination Methods 0.000 description 2
230000005489 elastic deformation Effects 0.000 description 2
239000000284 extract Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
239000010408 film Substances 0.000 description 2
230000005484 gravity Effects 0.000 description 2
238000009499 grossing Methods 0.000 description 2
230000006872 improvement Effects 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
238000005192 partition Methods 0.000 description 2
239000011241 protective layer Substances 0.000 description 2
238000003908 quality control method Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
210000001525 retina Anatomy 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
238000010079 rubber tapping Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000007779 soft material Substances 0.000 description 2
238000004381 surface treatment Methods 0.000 description 2
210000003582 temporal bone Anatomy 0.000 description 2
230000002123 temporal effect Effects 0.000 description 2
210000003813 thumb Anatomy 0.000 description 2
238000010200 validation analysis Methods 0.000 description 2
230000000007 visual effect Effects 0.000 description 2
UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
229920002430 Fibre-reinforced plastic Polymers 0.000 description 1
241000264877 Hippospongia communis Species 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000032683 aging Effects 0.000 description 1
210000003423 ankle Anatomy 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000004397 blinking Effects 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
210000000959 ear middle Anatomy 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000003054 facial bone Anatomy 0.000 description 1
239000011151 fibre-reinforced plastic Substances 0.000 description 1
210000001061 forehead Anatomy 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000009434 installation Methods 0.000 description 1
239000012212 insulator Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000001788 irregular Effects 0.000 description 1
238000005304 joining Methods 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
210000002414 leg Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000000116 mitigating effect Effects 0.000 description 1
239000004745 nonwoven fabric Substances 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000006069 physical mixture Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011158 quantitative evaluation Methods 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
239000005060 rubber Substances 0.000 description 1
230000035807 sensation Effects 0.000 description 1
230000008054 signal transmission Effects 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
229920002803 thermoplastic polyurethane Polymers 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000012795 verification Methods 0.000 description 1